Concepedia

Christopher Maslen

CM

3

Publications

124

Citations

3

H-Index

1988

Active since

Affiliations

Barking and Dagenham College(Current)

Christopher Maslen is an author at Barking and Dagenham College specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyDrug ResistanceChemical BiologyDrug DevelopmentNatural SciencesMolecular Pharmacology

Publications per year

1988–2001

3

Publications

3

The biosynthetic implications of acetate and glutamate incorporation into (3R,5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by Serratia sp.

Barrie W. Bycroft, Christopher Maslen, Stephen J. Box et al. · The Journal of Antibiotics · 1988 · 47 citations

RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency

Alan Collis, Martyn Foster, Frank Halley et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 40 citations · Full text

Vitro Potency, P38 Inhibitor Rpr200765a, Biochemistry +11

Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP‐specific phosphodiesterase

John E. Souness, Christopher Maslen, Lisa C. Scott · FEBS Letters · 1992 · 37 citations

Molecular Pharmacology, Biochemistry, Antiparasitic Agent +12

Rows per page

1–3 of 3